---
figid: PMC9118050__CAC2-42-401-g003
figtitle: 'Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities'
organisms:
- Adenoviridae
- Adeno-associated virus
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC9118050
filename: CAC2-42-401-g003.jpg
figlink: /pmc/articles/PMC9118050/figure/cac212291-fig-0002/
number: F2
caption: 'Molecular mechanisms of fibroblast activation. CXCL12 and TGF‐β activate
  fibroblasts by binding to CXCR4 and TGF‐β receptors, respectively, inducing the
  upregulation of α‐SMA and secretion of TGF‐β and CXCL12. Wnt7a also activates fibroblasts
  by binding to the TGF‐β receptor. TGF‐β and PDGF downregulate IDH3α by binding to
  the TGF‐β receptor and PDGFR, respectively. Downregulation of IDH3α increased the
  levels of effective α‐KG and HIF1α, resulting in enhanced glycolysis and attenuated
  OXPHOS. The binding of OPN to CD44 and integrin αvβ3 activate fibroblasts via AKT
  and ERK signaling pathway, respectively, which converge to upregulate α‐SMA, FSP1
  and FAP, and the activated fibroblasts secrete increased CXCL1, CXCL2, COX2, IL‐6,
  OPN and collagen. Exosomal miR‐9 increases the motility of fibroblasts and upregulate
  α‐SMA expression. Exosomal miR‐125b downregulates TP53INP1 and TP53, activating
  fibroblasts characterized by upregulated α‐SMA. Exosomal miR‐222 reduces LBR expression
  and increases α‐SMA and FSP1 expression. Exosomal miR‐146a downregulates TXNIP,
  activating the β‐catenin pathway and upregulating α‐SMA and FAP expression. MiR‐370‐3p
  from exosomes downregulates CYLD and upregulates NFκB, increasing the motility and
  paracrine signaling of IL‐1β, IL‐6 and IL‐8 in fibroblasts. Exosomal survivin increases
  the motility of fibroblasts and upregulates the levels of α‐SMA and vimentin. Abbreviations:
  TGF‐β, transforming growth factor beta; CXCL12, C‐X‐C motif chemokine ligand 12;
  CXCR4, C‐X‐C motif chemokine receptor 4; PDGF, platelet‐derived growth factor; PDGFR,
  platelet‐derived growth factor receptor; IDH3α, isocitrate dehydrogenase 3α; α‐KG,
  α‐ketoglutarate; HIF1α, hypoxia inducible factor 1 subunit alpha; OXPHOS, oxidative
  phosphorylation; OPN, osteopontin; AKT, AKT serine/threonine kinase; ERK, mitogen‐activated
  protein kinase 1; α‐SMA, alpha smooth muscle actin; FSP1, fibroblast‐specific protein‐1;
  FAP, fibroblast activation protein alpha; COX2, cyclooxygenase‐2; IL, interleukin;
  OPN, osteopontin; TP53INP1, tumor protein p53 inducible nuclear protein 1; LBR,
  lamin B receptor; TXNIP, thioredoxin interacting protein; CYLD, cylindromatosis;
  NFκB, nuclear factor kappa B subunit 1'
papertitle: 'Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities.'
reftext: Dengdi Hu, et al. Cancer Commun (Lond). 2022 May;42(5):401-434.
year: '2022'
doi: 10.1002/cac2.12291
journal_title: Cancer Communications
journal_nlm_ta: Cancer Commun (Lond)
publisher_name: John Wiley and Sons Inc.
keywords: Cancer‐associated fibroblasts | breast cancer | therapeutic target | tumor
  microenvironment | biomarker | tumor heterogeneity
automl_pathway: 0.893429
figid_alias: PMC9118050__F2
figtype: Figure
redirect_from: /figures/PMC9118050__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9118050__CAC2-42-401-g003.html
  '@type': Dataset
  description: 'Molecular mechanisms of fibroblast activation. CXCL12 and TGF‐β activate
    fibroblasts by binding to CXCR4 and TGF‐β receptors, respectively, inducing the
    upregulation of α‐SMA and secretion of TGF‐β and CXCL12. Wnt7a also activates
    fibroblasts by binding to the TGF‐β receptor. TGF‐β and PDGF downregulate IDH3α
    by binding to the TGF‐β receptor and PDGFR, respectively. Downregulation of IDH3α
    increased the levels of effective α‐KG and HIF1α, resulting in enhanced glycolysis
    and attenuated OXPHOS. The binding of OPN to CD44 and integrin αvβ3 activate fibroblasts
    via AKT and ERK signaling pathway, respectively, which converge to upregulate
    α‐SMA, FSP1 and FAP, and the activated fibroblasts secrete increased CXCL1, CXCL2,
    COX2, IL‐6, OPN and collagen. Exosomal miR‐9 increases the motility of fibroblasts
    and upregulate α‐SMA expression. Exosomal miR‐125b downregulates TP53INP1 and
    TP53, activating fibroblasts characterized by upregulated α‐SMA. Exosomal miR‐222
    reduces LBR expression and increases α‐SMA and FSP1 expression. Exosomal miR‐146a
    downregulates TXNIP, activating the β‐catenin pathway and upregulating α‐SMA and
    FAP expression. MiR‐370‐3p from exosomes downregulates CYLD and upregulates NFκB,
    increasing the motility and paracrine signaling of IL‐1β, IL‐6 and IL‐8 in fibroblasts.
    Exosomal survivin increases the motility of fibroblasts and upregulates the levels
    of α‐SMA and vimentin. Abbreviations: TGF‐β, transforming growth factor beta;
    CXCL12, C‐X‐C motif chemokine ligand 12; CXCR4, C‐X‐C motif chemokine receptor
    4; PDGF, platelet‐derived growth factor; PDGFR, platelet‐derived growth factor
    receptor; IDH3α, isocitrate dehydrogenase 3α; α‐KG, α‐ketoglutarate; HIF1α, hypoxia
    inducible factor 1 subunit alpha; OXPHOS, oxidative phosphorylation; OPN, osteopontin;
    AKT, AKT serine/threonine kinase; ERK, mitogen‐activated protein kinase 1; α‐SMA,
    alpha smooth muscle actin; FSP1, fibroblast‐specific protein‐1; FAP, fibroblast
    activation protein alpha; COX2, cyclooxygenase‐2; IL, interleukin; OPN, osteopontin;
    TP53INP1, tumor protein p53 inducible nuclear protein 1; LBR, lamin B receptor;
    TXNIP, thioredoxin interacting protein; CYLD, cylindromatosis; NFκB, nuclear factor
    kappa B subunit 1'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CXCL12
  - CXCR4
  - WNT7A
  - TGFB1
  - TGFB2
  - TGFB3
  - SMAD2
  - SMAD3
  - KAT2B
  - ACTA1
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - IDH3A
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - HIF1A
  - S100A4
  - ATL1
  - AIFM2
  - PDGFRB
  - PDGFRA
  - CD44
  - AKT1
  - AKT2
  - AKT3
  - SPP1
  - TWIST1
  - APP
  - SUCLA2
  - EPHB2
  - MAPK1
  - MAPK3
  - FAP
  - CEL
  - GLMN
  - CXCL1
  - CXCL2
  - COX2
  - PTGS2
  - MTCO2P12
  - IL6
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - TP53INP1
  - TP53
  - MIR146A
  - MIR222
  - TBX1
  - LBR
  - TXNIP
  - CTNNB1
  - CYLD
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CXCL8
  - Cxcl12
  - Cxcr4
  - Wnt7a
  - Tgfb1
  - Ltbp1
  - Smad2
  - Smad3
  - Caf
  - Acta2
  - Idh3a
  - Hif1a
  - S100a4
  - Aifm2
  - Atl1
  - Pdgfrb
  - Cd44
  - Akt1
  - Spp1
  - Twist1
  - App
  - H2-Ab1
  - Ephb2
  - Mapk1
  - Fap
  - Cxcl1
  - Cxcl2
  - Ptgs2
  - Il6
  - Trp53inp1
  - Trp53
  - Mir146
  - Mir222
  - Lbr
  - Txnip
  - Ctnnb1
  - Cyld
  - Nfkb1
  - Cxcl15
  - cxcl12a
  - cxcr4b
  - wnt7aa
  - smad2
  - smad3a
  - idh3a
  - hif1ab
  - cd4-1
  - fap
  - il6
  - tp53inp1
  - tp53
  - mir146a
  - dre-mir-222
  - lbr
  - txnipa
  - ctnnb1
  - cylda
  - cxcl8a
  - birc5a
---
